D-amphetamine and d-methamphetamine immunoassay reagent kits for tamc forensic toxicology drug testing laboratory (ftdtl)
Ended Awarded Last action
- Contract number
- W81K0225FA042
- Awardee
-
Microgenics Corporation UEI E7WGWEK19Y79
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $22,416
Award facts
- Contract value 100% obligated
- $22,416.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fremont, CA 94538, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $22,416 firm fixed-price delivery order to Microgenics Corporation on May 13, 2025, for d-amphetamine and d-methamphetamine immunoassay reagent kits to support the Tripler Army Medical Center (TAMC) Forensic Toxicology Drug Testing Laboratory. The contract, which carries an ultimate completion date of August 26, 2025, represents a delivery order under a larger indefinite delivery vehicle and does not utilize a set-aside designation. Microgenics, a clinical diagnostics division of Thermo Electron Corporation based in Fremont, California, specializes in high-precision immunoassay reagent test kits for substance detection and toxicology screening purposes.
This award reflects Microgenics' established role as a key supplier of diagnostic reagents to the Department of Defense Drug Demand Reduction Program and broader military healthcare systems. The company holds multiple single-award indefinite delivery contracts valued at over $9 million collectively, providing reagent kits for detecting various controlled substances including benzodiazepines, opiates, and amphetamines to the Navy Bureau of Medicine and Surgery, Defense Health Agency, and Veterans Affairs agencies. The reagent kits delivered under this contract will enable TAMC's forensic toxicology laboratory to conduct accurate substance abuse testing and screening in support of military medical operations and readiness initiatives.
Quick answers
Who was awarded contract W81K0225FA042?
W81K0225FA042 was awarded to Microgenics Corporation by Medical Command (Department of the Army) on May 13, 2025.
How much is contract W81K0225FA042 worth?
The government has obligated $22,416 on W81K0225FA042.
Which agency awarded contract W81K0225FA042?
Medical Command (Department of the Army) awarded W81K0225FA042, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0225FA042 an order under another contract?
Yes. W81K0225FA042 is a delivery order under N0018925DZ006, an indefinite delivery contract.
Was contract W81K0225FA042 competed?
The extent of competition for W81K0225FA042 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award